RecensMedical, Inc. (KOSDAQ:394420)
South Korea · Delayed Price · Currency is KRW 17,250
-900 (-4.96%)
At close: Jun 12, 2026
RecensMedical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -17,378 | -19,119 | -7,844 | -7,572 | -40,994 |
Depreciation & Amortization | 556.14 | 509.91 | 388.72 | 524.36 | 424.46 |
Loss (Gain) From Sale of Assets | - | - | - | 66.17 | - |
Stock-Based Compensation | 914.42 | 841.38 | 442.16 | 1,886 | 1,642 |
Provision & Write-off of Bad Debts | 441.77 | 423.81 | 1,738 | 158.07 | - |
Other Operating Activities | 7,823 | 9,213 | -5,550 | -4,659 | 21,955 |
Change in Accounts Receivable | -1,347 | -1,232 | -1,123 | -3,266 | -15.4 |
Change in Inventory | -480 | 271.06 | 2,090 | -705.44 | -4,591 |
Change in Accounts Payable | -525.6 | 468.91 | -462.51 | 355.64 | -191.34 |
Change in Other Net Operating Assets | -104.09 | 28.73 | 587.32 | -65.8 | -251.05 |
Operating Cash Flow | -10,099 | -8,594 | -9,733 | -13,278 | -22,022 |
Capital Expenditures | -848.18 | -760.59 | -482.58 | -251.62 | -717.77 |
Sale of Property, Plant & Equipment | - | - | 0.15 | - | - |
Sale (Purchase) of Intangibles | -148.12 | -46.25 | -4.6 | -1.87 | -184.3 |
Investment in Securities | 2,000 | 5,000 | -5,000 | 7,033 | -6,533 |
Other Investing Activities | -43.99 | 211.14 | 64.04 | -20 | -19.69 |
Investing Cash Flow | 959.72 | 4,404 | -5,423 | 6,743 | -7,454 |
Short-Term Debt Issued | - | 950 | - | - | - |
Long-Term Debt Issued | - | - | - | - | 500 |
Total Debt Issued | 7,950 | 950 | - | - | 500 |
Short-Term Debt Repaid | - | -950 | - | - | - |
Long-Term Debt Repaid | - | -330.23 | -285.2 | -414.17 | -293.49 |
Total Debt Repaid | -3,302 | -1,280 | -285.2 | -414.17 | -293.49 |
Net Debt Issued (Repaid) | 4,648 | -330.23 | -285.2 | -414.17 | 206.51 |
Issuance of Common Stock | 16,035 | 338.54 | 727.88 | 76.4 | 33.9 |
Other Financing Activities | -0 | -0 | - | -6.42 | - |
Financing Cash Flow | 20,684 | 8.31 | 17,724 | -344.19 | 35,202 |
Foreign Exchange Rate Adjustments | 15.01 | -127.68 | 157.07 | 48.64 | -81.93 |
Net Cash Flow | 11,560 | -4,309 | 2,725 | -6,831 | 5,643 |
Free Cash Flow | -10,947 | -9,354 | -10,215 | -13,530 | -22,740 |
Free Cash Flow Margin | -144.09% | -105.95% | -163.20% | -234.47% | -8070.77% |
Free Cash Flow Per Share | -1353.63 | -1413.99 | -2984.99 | -4079.06 | -6885.21 |
Cash Interest Paid | 103.45 | 56.53 | 38.97 | 112.82 | - |
Cash Income Tax Paid | 23.31 | 26.6 | -26.89 | 13.84 | 5.7 |
Levered Free Cash Flow | - | -77,913 | -19,126 | -19,248 | - |
Unlevered Free Cash Flow | - | -76,408 | -16,690 | -17,333 | - |
Change in Working Capital | -2,457 | -462.91 | 1,092 | -3,682 | -5,049 |